| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/14/1995 | CA2185027A1 Methods for modulating t cell unresponsiveness |
| 09/14/1995 | CA2184905A1 Corpuscles of stannius protein, stanniocalcin |
| 09/14/1995 | CA2184902A1 Vaccine compositions |
| 09/14/1995 | CA2184833A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
| 09/14/1995 | CA2184583A1 Transforming growth factor alpha h1 |
| 09/14/1995 | CA2183963A1 Dirofilaria immitis gp29 proteins, nucleic acid molecules and uses thereof |
| 09/14/1995 | CA2183898A1 Nucleotide or nucleosidephotoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics |
| 09/13/1995 | EP0671472A1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 09/13/1995 | EP0670905A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 09/13/1995 | EP0670904A1 Vector for the expression of therapy-relevant genes |
| 09/13/1995 | EP0670901A1 Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus |
| 09/13/1995 | EP0670899A1 Heat shock proteins and the treatment of tumours |
| 09/13/1995 | EP0670734A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| 09/13/1995 | EP0670733A1 Compositions containing growth factors and antiplastic agents |
| 09/13/1995 | EP0670726A1 Treatment of hiv infection with humic acid |
| 09/13/1995 | EP0475936B1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| 09/13/1995 | CN1108306A Reconstituted hepatitis B vaccine with corboxy end having anterior surface antigen 1 determinant |
| 09/12/1995 | US5449765 DNA encoding amino acids 590-710 of glycoprotein gII of pseudorabies virus |
| 09/12/1995 | US5449760 Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils |
| 09/12/1995 | US5449753 Autotaxin: motility stimulating protein useful in cancer diagnosis |
| 09/12/1995 | US5449616 Nucleic acid encoding dystrophin-associated protein |
| 09/12/1995 | US5449608 Detection |
| 09/12/1995 | CA1336956C Pasteurella multocida vaccine |
| 09/12/1995 | CA1336955C Respiratory syncytial virus: vaccines and diagnostic assays |
| 09/12/1995 | CA1336954C Treatment of autoimmune diseases by oral administration of autoantigens |
| 09/08/1995 | WO1995023970A1 Assay for the diagnosis of schizophrenia |
| 09/08/1995 | WO1995023865A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
| 09/08/1995 | WO1995023848A1 Selective virus culture |
| 09/08/1995 | WO1995023846A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 09/08/1995 | WO1995023814A1 Product and process for t cell regulation |
| 09/08/1995 | WO1995023607A1 Antibacterial agent containing tea extract or active fraction thereof and beta-lactam antibiotic |
| 09/08/1995 | WO1995019429A3 Method and reagent for inhibiting hepatitis c virus replication |
| 09/08/1995 | CA2184810A1 Product and process for t cell regulation |
| 09/08/1995 | CA2184602A1 Assay for the diagnosis of schizophrenia |
| 09/08/1995 | CA2184354A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 09/08/1995 | CA2181787A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
| 09/06/1995 | EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it |
| 09/06/1995 | EP0669988A1 Angiogenesis inhibitory antibodies |
| 09/06/1995 | EP0669987A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 09/06/1995 | EP0669985A1 Conjugate vaccine against group b streptococcus |
| 09/06/1995 | EP0669984A1 Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 09/06/1995 | EP0669983A1 Allergenic proteins and peptides from japanese cedar pollen |
| 09/06/1995 | EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 09/06/1995 | EP0669980A1 Method of controlling polypeptide production in bacteria |
| 09/06/1995 | EP0669979A1 C-c ckr-1, c-c chemokine receptor |
| 09/06/1995 | EP0669978A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 09/06/1995 | EP0669976A1 Transcription factor dp-1 |
| 09/06/1995 | EP0669971A1 Gram-negative bacterial vaccines |
| 09/06/1995 | EP0669942A1 Artificial antibodies, method of producing the same and use thereof |
| 09/06/1995 | EP0669941A1 Method of reducing multidrug resistance in cells and tissues |
| 09/06/1995 | EP0669930A1 Cellular genes encoding retinoblastoma-associated proteins |
| 09/06/1995 | EP0669829A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 09/06/1995 | EP0474797B1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof |
| 09/06/1995 | EP0419569B1 Stress proteins and uses therefor |
| 09/06/1995 | EP0151579B1 Method and products for detection of human t cell leukemia virus |
| 09/06/1995 | CN1108030A New sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 09/05/1995 | US5447853 Culture and separation of cells |
| 09/05/1995 | US5447852 DNA encoding cyclophilin C, and recombinant methods employing it |
| 09/05/1995 | US5447840 Receptor of the small rhinovirus receptor group |
| 09/05/1995 | US5447722 Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals |
| 09/05/1995 | CA1336887C Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| 08/31/1995 | WO1995023234A1 Isolated, tyrosinase derived peptides and uses thereof |
| 08/31/1995 | WO1995023226A1 Gene for mycobacterial diaminopimelic acid |
| 08/31/1995 | WO1995023219A1 Immortalized feline cells and uses therefor |
| 08/31/1995 | WO1995023218A1 Immortalized canine cells and uses therefor |
| 08/31/1995 | WO1995023214A1 Method for stimulating profileration of colon cells using pomc¿76-103? |
| 08/31/1995 | WO1995023166A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 08/31/1995 | WO1995023164A1 A t cell receptor sequence specifically associated with an immune disease |
| 08/31/1995 | WO1995022990A1 Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition |
| 08/31/1995 | WO1995022989A1 Vaccines containing paucilamellar lipid vesicles as immunological adjuvants |
| 08/31/1995 | WO1995022988A1 Vacuolating toxin-deficient h. pylori and related methods |
| 08/31/1995 | WO1995022987A1 Urease-based vaccine and treatment for helicobacter infection |
| 08/31/1995 | WO1995022986A1 Fibrin-specific antibody for use as an antithrombotic agent |
| 08/31/1995 | WO1995022980A1 Inhibin compositions and methods of use thereof |
| 08/31/1995 | WO1995022978A1 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 08/31/1995 | WO1995022977A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/31/1995 | WO1995022961A1 Liposomes and use thereof especially to obtain immunomodulating compositions |
| 08/31/1995 | CA2184176A1 Method for stimulating profileration of colon cells using pomc76-103 |
| 08/31/1995 | CA2184057A1 Urease-based vaccine and treatment for helicobacter infection |
| 08/31/1995 | CA2183977A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 08/31/1995 | CA2183953A1 Fibrin-specific antibody for use as an antithrombotic agent |
| 08/31/1995 | CA2183769A1 Vacuolating toxin-deficient h. pylori and related methods |
| 08/31/1995 | CA2183535A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/31/1995 | CA2161682A1 Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition |
| 08/30/1995 | EP0669133A1 Paramunity inducer based ou combinations of poxvirus components, process to prepore it and its use as medicament |
| 08/30/1995 | EP0668923A1 Monoclonal antibody |
| 08/30/1995 | EP0668918A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 08/30/1995 | EP0668916A1 Haemophilus outer membrane protein |
| 08/30/1995 | EP0668915A1 Protein allergens of the species cynodon dactylon |
| 08/30/1995 | EP0668908A1 Specific dna sequences of a nematode which can be used for the diagnosis of infection with the nematode |
| 08/30/1995 | EP0668876A1 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 08/30/1995 | EP0668871A1 Amino-acid sequence homologies between selectins and b. pertussis toxin-peptidesderived therfrom, antibodies thereto and pharmaceutical compositions |
| 08/30/1995 | EP0668781A1 Lymphokine gene therapy of cancer |
| 08/30/1995 | EP0668780A1 Virulence-specific bacterial dna sequence |
| 08/30/1995 | EP0668779A1 COMPOSITION PROTECTIVE AGAINST $i(P. MULTOCIDA) PASTEURELLOSIS INFECTION |
| 08/30/1995 | EP0668778A1 IMMUNIZATION AGAINST $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS) |
| 08/30/1995 | EP0668777A1 Prostate-specific membrane antigen |
| 08/30/1995 | EP0668774A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis |
| 08/30/1995 | EP0668772A1 Specific immune system modulation |
| 08/30/1995 | EP0668771A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |